We reassigned CEA, CYFRA21-1 and NSE based on their distribution in different groups, as TM levels of some people without LC exceed the reference value while that of some LC patients are lower than the reference value [18–20]. The gene discussed is ENO2; the disease is laryngotracheoesophageal cleft.